Serum Levels of Syndecan-1, Interleukin-6 and C-Reactive Protein in Statin-Treated Patients with Type 2 Diabetes Mellitus

Journal Title: Journal of Endocrinology and Diabetes - Year 2015, Vol 2, Issue 5

Abstract

This study was undertaken to evaluate the alterations of serum levels of syndecan-1, lipids, interleukin-6 and C-reactive protein in type 2 diabetic patients and to assess the possible effect of statins on syndecan-1 level targeting the prevention of pathologic inflammatory events in these patients.

Authors and Affiliations

Mohamed AbdEllatif Mahmoud

Keywords

Related Articles

Iatrogenic Milk Alkali Syndrome in a Patient Recovering from Acute Renal Failure

We describe a 49 year old morbidly obese man with iatrogenic milk alkali syndrome. He presented with sepsis resulting in acute renal failure with resultant hyperphosphatemia treated with high dose calcium carbonate. As h...

Why OSA may be Regarded as the Real Hidden Killer in Diabetes

Obstructive Sleep Apnea Syndrome (OSAS) is a common and usually overlooked phenomenon causing a deep reduction in oxygen delivery to the body tissues and a serious disruption of the sleep pattern. Furthermore there are s...

Do We Still Need Pioglitazone for The Management of Type 2 Diabetes Mellitus? A Peep In To Risk of Bladder Cancer in Diabetic Population

Pioglitazone use and risk of bladder cancer in diabetic patient one of the major cause of morbidity and mortality. Increasing evidence from the clinical studies suggested increased risk of bladder cancer with higher dose...

HSP27 and Atherogenic Index of the Plasma - heralding cardiovascular complications inIndian diabetic subjects

Aim: To evaluate the importance of Heat shock protein 27 (HSP27) and Atherogenic Index of the Plasma (AIP) in diabetic subjects, as indicators of cardiovascular disease progression in diabetic subjects. Materials and Me...

Effect of Age, Gender and Season on Thyroid Hormones Status in Children of East Delhi- A Hospital Based Study

Background: Thyroid hormones are the most commonly prescribed tests in the clinical set up. Variations are observed in individuals of different age, sex, race and nutritional status. However few studies describe these ch...

Download PDF file
  • EP ID EP333345
  • DOI 10.15226/2374-6890/2/5/00137
  • Views 88
  • Downloads 0

How To Cite

Mohamed AbdEllatif Mahmoud (2015). Serum Levels of Syndecan-1, Interleukin-6 and C-Reactive Protein in Statin-Treated Patients with Type 2 Diabetes Mellitus. Journal of Endocrinology and Diabetes, 2(5), 1-1. https://europub.co.uk/articles/-A-333345